Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
49.00
-0.11 (-0.22%)
At close: Nov 5, 2025, 4:00 PM EST
48.93
-0.07 (-0.14%)
Pre-market: Nov 6, 2025, 4:14 AM EST
Sanofi Revenue
Sanofi had revenue of 13.17B EUR in the quarter ending September 30, 2025, a decrease of -6.97%. This brings the company's revenue in the last twelve months to 45.93B, down -5.19% year-over-year. In the year 2024, Sanofi had annual revenue of 44.29B with 7.73% growth.
Revenue (ttm)
45.93B EUR
Revenue Growth
-5.19%
P/S Ratio
2.21
Revenue / Employee
554,200 EUR
Employees
82,878
Market Cap
119.04B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
| Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
| Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
| Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
| Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SNY News
- 9 days ago - UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey - GlobeNewsWire
- 12 days ago - Sanofi: Is Dupixent Too Successful? - Seeking Alpha
- 12 days ago - Sanofi Q3: Cash-Rich, Cheap, And Loading 2026 Shots On Goal - Seeking Alpha
- 12 days ago - Sanofi (SAN:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark - Benzinga
- 13 days ago - Sanofi Earnings Driven by New Medicine Sales, Dupixent Performance - WSJ
- 13 days ago - Sanofi's quarterly profit boosted by Dupixent and newer drugs, forecast unchanged - Reuters
- 13 days ago - Press release: Q3: continued sales and earnings progress - GlobeNewsWire